ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cholangiocarcinoma
Related studies linked through entity extraction aliases.
Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors
- Status
- UNKNOWN
- Phase
- NA
Endobiliary Radiofrequency Ablation With S-1 for Unresectable Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety of Photodynamic Therapy for Unresectable Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- NA
Endoscopic Biliary RFA of Malignant Bile Duct Obstruction
- Status
- UNKNOWN
- Phase
- NA
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Metformin And Chloroquine in IDH1/2-mutated Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck
- Status
- TERMINATED
- Phase
- PHASE2
Radiofrequency Ablation for Biliopancreatic Malignancy
- Status
- COMPLETED
- Phase
- PHASE2
Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line Therapy
- Status
- TERMINATED
- Phase
- PHASE2
In Vitro Models of Liver and Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- N/A
Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- Status
- RECRUITING
- Phase
- PHASE1
Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder
- Status
- COMPLETED
- Phase
- PHASE1